Leqembi

Active Ingredient(s): Lecanemab-irmb
FDA Approved: * January 6, 2023
Pharm Company: * EISAI INC
Category: Alzheimers / Dementia
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Leqembi 100 mg/ml Intravenous Injection, Solution
NDC: 62856-212
Labeler:
Eisai Inc.
Leqembi 100 mg/ml Intravenous Injection, Solution
NDC: 62856-215
Labeler:
Eisai Inc.